Novasep (Pompey, France) has announced an investment of €30 million into the construction of the world’s largest pharmaceutical chromatography plant.
Novasep (Pompey, France) has announced an investment of €30 million into the construction of the world’s largest pharmaceutical chromatography plant. The plant will be located on Novasep’s existing Mourenx site in France and will be used for the production of a large volume commercial API (active pharmaceutical ingredient).
The plant will be designed and planned by the company’s in-house engineers, with plans for the plant to be operational and validated within 18 months. The investment follows the projection of a rapid increase in demand for large volume, highly purified API from complex mixtures. The systems within the plant will reportedly incorporate solvent recovery systems for the recovery of 99.9% of solvents reducing environmental impacts of the plant.
"Demand for Novasep's advanced, purification-based manufacturing capabilities in the life science industries continues to increase as drugs in development and reaching the market become more complex and specific. This necessitates our third and largest global plant expansion in 2012," commented Patrick Glaser, President and CEO of Novasep." This project demonstrates the validity of the Novasep strategy which is based on the combination of synthesis, biosynthesis and purification. We thank our institutional partners for their active support and our shareholders for their strong involvement to enable this transforming project."
For more information please visit:
ref=http://www.novasep.com >www.novasep.com
New Study Investigates Optimizing Extra-Column Band Broadening in Micro-flow Capillary LC
March 12th 2025Shimadzu Corporation and Vrije Universiteit Brussel researchers recently investigated how extra-column band broadening (ECBB) can be optimized in micro-flow capillary liquid chromatography.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.